Exacerbation of Allergic Diseases After COVID-19 Vaccination: A Multicenter Observational Study
Concerns about worsening allergic disease may contribute to vaccine hesitancy. We evaluated the frequency, severity, and factors associated with self-reported exacerbations after COVID-19 vaccination and described findings after influenza vaccination. In this multicenter observational survey, adults with physician-diagnosed allergic diseases were prospectively enrolled at 14 Korean allergy centers, while vaccination history and post-vaccination outcomes were retrospectively ascertained. Severe exacerbation was defined as requiring emergency department care or hospitalization. Among 1626 COVID-19-vaccinated patients, 281 (17.3%) reported exacerbation; 36 (12.8% of exacerbators; and 2.2% of all vaccinated patients) were severe. Female sex, chronic urticaria, and atopic dermatitis were independently associated with any exacerbation, whereas increasing age and allergic rhinitis were associated with lower odds. Bronchial asthma was independently associated with severe exacerbation (adjusted OR, 3.07; 95% CI, 1.10–8.51). No factor was associated with multiple exacerbations. Biologic therapy and allergen immunotherapy were not associated with increased risk. Exacerbations were reported in 16 of 786 influenza-vaccinated patients (2.0%) and were generally mild. Although self-reported symptom worsening after COVID-19 vaccination was relatively common, severe events were uncommon. COVID-19 vaccination was generally well tolerated, including among patients receiving biologics or allergen immunotherapy.
Authors
- Ga‐Young Ban (ORCID: https://orcid.org/0000-0002-7961-742X)
- Jeong‐Hee Choi (ORCID: https://orcid.org/0000-0002-0599-875X)
- Mi‐Ae Kim (ORCID: https://orcid.org/0000-0003-1253-6075)
- Hyun Young Lee (ORCID: https://orcid.org/0000-0003-4169-8284)
- Seong‐Dae Woo (ORCID: https://orcid.org/0000-0003-2506-7407)
- H. J. Lee
- Gil‐Soon Choi (ORCID: https://orcid.org/0000-0003-3466-3294)
- Gyu Young Hur (ORCID: https://orcid.org/0000-0001-5039-0199)
- Chang‐Gyu Jung (ORCID: https://orcid.org/0000-0001-9163-9253)
- Young‐Min Ye (ORCID: https://orcid.org/0000-0002-7517-1715)
- Sang‐Ha Kim (ORCID: https://orcid.org/0000-0002-1763-5366)
- Ji-Ho Lee (ORCID: https://orcid.org/0000-0001-8744-156X)
- Joo‐Hee Kim (ORCID: https://orcid.org/0000-0002-1572-5149)
- Hyun Jung Jin
- Young-Hee Nam (ORCID: https://orcid.org/0000-0001-8759-2982)
- Hyo-In Rhyou
- Youngsoo Lee
Institutions
- Hallym University (KR)
- Yonsei University (KR)
- Chungnam National University (KR)
- Korea University (KR)
- Korea University Medical Center (KR)
- Kosin University Gospel Hospital (KR)
- Sacred Heart Hospital (US)
- St. Mary's Hospital (US)
- Inje University Haeundae Paik Hospital (KR)
- CHA University Bundang Medical Center (KR)
- Kangdong Sacred Heart Hospital (KR)
- CHA University (KR)
- Yeungnam University Medical Center (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Yonsei University Mirae Campus (KR)
- Ajou University Medical Center (KR)
- Dong-A University (KR)
- Keimyung University (KR)
- Yeungnam University (KR)
- Ajou University (KR)
- Catholic University of Korea (KR)
- Kosin University (KR)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/ijms272210277
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Food and Drug Safety
- National Research Foundation of Korea